Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc Stock, NASDAQ:TERN
Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong and is headquartered in Foster City, CA.